Oral Hypoglycemic Agents
IDENTIFICATION, ASSESSMENT AND ANALYSING THE COST EFFECTIVENESS OF ORAL HYPOGLYCEMIC AGENTS FOR PHARMACOECONOMIC EVALUATION IN A TERTIARY CARE TEACHING HOSPITAL
14
Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents
13
Impact of oral hypoglycemic agents on mortality among diabetic patients with non muscle invasive bladder cancer: A population based analysis
8
SAFETY OF INSULIN ADD ON THERAPY AND ORAL HYPOGLYCEMIC AGENTS (OHGAs) POLYPHARMACY IN TYPE II DIABETES PATIENTS A PROSPECTIVE OBSERVATIONAL STUDY
14
INCIDENCE OF ADVERSE DRUG REACTIONS AND DRUG INTERACTIONS OF ORAL HYPOGLYCEMIC AGENTS IN TYPE 2 DIABETIC PATIENTS AT GUWAHATHI MEDICAL COLLEGE HOSPITAL
8
A STUDY ON DRUG UTILIZATION PATTERN OF ORAL HYPOGLYCEMIC AGENTS IN TYPE-2 DIABETIC PATIENTS OF A TERTIARY CARE TEACHING HOSPITAL
8
Cost-effectiveness study of oral hypoglycemic agents in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City
9
Utilization Pattern of Oral Hypoglycemic Agents for Diabetes Mellitus Type 2 Patients Attending Out Patient Department at a University Hospital in New Delhi
10
PHARMACOECONOMICAL EVALUATION OF ORAL HYPOGLYCEMIC AGENTS FOR TYPE 2 DIABETES MELLITUS IN A MULTISPECIALITY HOSPITAL
6
Impact of oral hypoglycemic agents on mortality among diabetic patients with non muscle invasive bladder cancer: A population based analysis
21
Patterns of Adherence to Oral Hypoglycemic Agents: Patterns, Correlates, and Outcomes
78
Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents
9
Oral hypoglycemic agents: do the ends justify the means?
10
Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes
9
Effectiveness and safety of exenatide in Korean patients with type 2 diabetes inadequately controlled with oral hypoglycemic agents: an observational study in a real clinical practice
9
Utilization of Oral Hypoglycemic Agents in a Drug-Insured U.S. Population
5
COMPARE THE EFFICACY AND SAFETY OF DIPEPTIDYL PEPTIDASE 4 INHIBITORS WITH OTHER ORAL HYPOGLYCEMIC AGENTS IN TYPE 2 DIABETES MELLITUS PATIENTS
5
Vitamin B12 deficiency among vegetarian and non-vegetarian diabetic population receiving prolonged Metformin based oral hypoglycemic agents therapy
5
Study of Prescription Pattern of Oral Hypoglycemic Agents in Relation to Gfr Appropriateness in Diabetes Mellitus with Nephropathy
7
DIAGNOSIS AND TREATMENT: SHOULD ORAL HYPOGLYCEMIC AGENTS BE USED IN PEDIATRIC AND PREGNANT PATIENTS?
7